Post job

Rutgers Cancer Institute of New Jersey CEO and executives

Executive Summary. Based on our data team's research, John Goldner is the Rutgers Cancer Institute of New Jersey's CEO. Rutgers Cancer Institute of New Jersey has 50 employees, of which 11 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Rutgers Cancer Institute of New Jersey executive team is 36% female and 64% male.
  • 69% of the management team is White.
  • 12% of Rutgers Cancer Institute of New Jersey management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Rutgers Cancer Institute of New Jersey?
Share your experience

Rate Rutgers Cancer Institute of New Jersey's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
John Goldner

CEO

Susan Solometo

System Vice President For Strategy and Operations, Oncology Services, Rwjbarnabas Health

Adam Berger

MD

Bryan Soltes

System Vice President For Network Development

David A. August

Board Member

Deborah L. Toppmeyer

MD, Chief Medical Officer and, Chief

Steven K. Libutti

MD

Bruce G. Haffty

MD

Henry A. Pitt

MD, Chief of Oncologic Quality

Linda Tanzer

Board Member

Do you work at Rutgers Cancer Institute of New Jersey?

Does leadership effectively guide Rutgers Cancer Institute of New Jersey toward its goals?

Rutgers Cancer Institute of New Jersey jobs

Rutgers Cancer Institute of New Jersey board members

Name & TitleBio
David A. August

Board Member

Linda Tanzer

Board Member

Laurie Smaldone

Board Member

Rutgers Cancer Institute of New Jersey leadership demographics

Rutgers Cancer Institute of New Jersey gender distribution in management team

  • The Rutgers Cancer Institute of New Jersey executive team is 36% female and 64% male.
  • Rutgers Cancer Institute of New Jersey is 63% female and 37% male company-wide.
Male
Male
64%
Company-wide: 37%
Female
Female
36%
Company-wide: 63%

Rutgers Cancer Institute of New Jersey executives by race

Management Team:
  • The most common ethnicity among Rutgers Cancer Institute of New Jersey executive officers is White.
  • 69% of the management team is White.
  • 12% of Rutgers Cancer Institute of New Jersey's management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 51% of employees are White.
  • 17% of employees are Asian.
  • 16% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Rutgers Cancer Institute of New Jersey jobs nearby

Rutgers Cancer Institute of New Jersey executives FAQs

Zippia gives an in-depth look into the details of Rutgers Cancer Institute of New Jersey, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rutgers Cancer Institute of New Jersey. The employee data is based on information from people who have self-reported their past or current employments at Rutgers Cancer Institute of New Jersey. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rutgers Cancer Institute of New Jersey. The data presented on this page does not represent the view of Rutgers Cancer Institute of New Jersey and its employees or that of Zippia.

Rutgers Cancer Institute of New Jersey may also be known as or be related to Cancer Institute of New Jersey Foundation, Cancer Institute of New Jersey Foundation Inc and Rutgers Cancer Institute of New Jersey.